ArticleProceedings of the National Academy of Sciences of the United States of America2019

Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.

Ivy X Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.